The effect of hyperglycemia on zinc, copper and chromium status in STZ-induced diabetic rats

Trace Elements and Electrolytes

Volumn 28, Issue 3, 2011, Pages 156-161

  Krejpcio, Z ^a   Wojciak R W ^a   Krol E ^a  

^a POZNA UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

Chromium; Copper; Diabetic rats; Streptozotocin; Zinc

Indexed keywords

CHROMIUM; COPPER; ZINC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CONTROLLED STUDY; DISEASE ASSOCIATION; EXPERIMENTAL RAT; HISTOPATHOLOGY; HYPERGLYCEMIA; KIDNEY; LIVER LEVEL; MALE; MINERAL METABOLISM; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN; STREPTOZOCIN DIABETES; TESTIS; TISSUE LEVEL;

RATTUS; RATTUS NORVEGICUS;

EID: 79959456513     PISSN: 09462104     EISSN: None     Source Type: Journal    
DOI: 10.5414/TEP28156     Document Type: Article

References (41)

1. Achenbach P, Lampasona V, Landherr U, Koczwara K, Krause S, Grallert H, Winkler C, Pflüger M, Illig T, Bonifacio E, Ziegler AG. Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk. Diabetologia. 2009; 52: 1881-1888.
2. Al-Maroof RA, Al-Sharbatti SS. Serum zinc levels in diabetic patients and effect of zinc supplementation on glycemic control of type 2 diabetics. Saudi Med J. 2006; 27: 344-345.
3. Boesgaard TW, Zilinskaite J, Vänttinen M, Laakso M, Jansson PA, Hammarstedt A, Smith U, Stefan N, Fritsche A, Häring H, Hribal M, Sesti G, Zobel DP, Pedersen O, Hansen T; EUGENE 2 Consortium. The common SLC30A8 Arg325Trp variant is associated with reduced first-phase insulin release in 846 non-diabetic offspring of type 2 diabetes patients - the EUGENE2 study. Diabetologia. 2008; 51: 816-820.
4. Car N, Car A, Granić M, Skrabalo Z, Momcilović B. Zinc and copper in the serum of diabetic patients. Biol. Trace Elem. Res. 1992; 32: 325-329
5. Chistiakov DA, Voronova NV. Zn(2+)-transporter-8: a dual role in diabetes. Biofactors. 2009; 35: 356-363.
6. 3]+ increases insulin sensitivty and improves blood plasma variables in healthy and type 2 diabetic rats. J. Biol. Inorg. Chem. 2005; 10: 119-130.
7. Davis CM, Sumrall KH, Vincent JB. A biologically active form of chromium may activate a membrane phosphotyrosine phosphatase (PTP). Biochemistry. 1996; 35: 12963-12969. (Pubitemid 26337354)
8. Davis CM, Vincent JR. Chromium oligopeptide activates insulin receptor tyrosine kinase activity. Biochemistry. 1997; 36: 4382-4385. (Pubitemid 27180283)
9. Dogukan A, Sahin N, Tuzcu M, Juturu V, Orhan C, Onderci M, Komorowski J, Sahin K. The Effects of Chromium Histidinate on Mineral Status of Serum and Tissue in Fat-Fed and Streptozotocin-Treated Type II Diabetic Rats. Biol. Trace Elem. Res. 2009; 131: 124-132.
10. Eaton JW, Qian M. Interactions of copper with glycated proteins: possible involvement in the etiology of diabetic neuropathy. Mol Cell Biochem. 2002; 234-235: 135-142. (Pubitemid 34777850)
11. Ekin S, Mert N, Gunduz H, Meral I. Serum sialic acid levels and selected mineral status in patients with type 2 diabetes mellitus. Biol. Trace Elem. Res. 2003; 94: 193-201.
12. Ekmekcioglu C, Prohaska C, Pomazal K, Steffan I, Schernthaner G, Marktl W. Concentrations of seven trace elements in different hematological matrices in patients with type 2 diabetes as compared to healthy controls. Biol. Trace Elem. Res. 2001; 79: 205-219.
13. Feng W, Quian Q, Ding W, Chai Z. Tissue contents and subcellular distribution of chromium and other trace metals in experimental diabetic rats after intravenous injection of Cr 50-enriched stable isotopic tracer solution. Metabolism. 2001; 50: 1168-1174. (Pubitemid 33036824)
14. Halliwell B, Gutteridge JMC. Role of free radicals and catalytic metal ions in human disease. Methods Enzymol. 1990; 186: 1-85. (Pubitemid 20279941)
15. Imbir T, Tamer L, Taylor A, Isbir M. Zinc, copper and magnesium status in insulin-dependent diabetes. Diabetes Res. 1994; 26: 41-45.
16. Jeejeebhoy KN, Chu RC, Marliss EB, Greenberg GR, Bruce-Robertson A. Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation in a patient receiving long-term total parenteral nutrition. Am. J. Clin. Nutr. 1977; 30: 531-538.
17. Kazi TG, Afridi HI, Kazi N, Jamali MK, Arain MB, Jalbani N, Kandhro GA. Copper, chromium, manganese, iron, nickel, and zinc levels in biological samples of diabetes mellitus patients. Biol Trace Elem Res. 2008; 122: 1-18.
18. Krejpcio Z, Wójciak RW, Staniek H. The concentration of calcium, magnesium and phosphorus In selected tissues of STZ-induced diabetic rats. Biol Trace Elem Res. 2008; 25: 213-218.
19. Krejpcio Z, Wójciak RW. The selected iron management parameters in STZ-induced diabetic rats. Biol Trace Elem Res. 2010; 27: 115-119.
20. Masood N, Baloch GH, Ghori RA, Memon IA, Memon MA, Memon MS. Serum zinc and magnesium in type-2 diabetic patients. J Coll Physicians Surg Pak. 2009; 19: 483-486.
21. McDermott BM, Flatt PR, Strain JJ. Effects of copper deficiency and experimental diabetes on tissue antioxidant enzyme levels in rats. Ann Nutr Metab. 1999; 38: 263-269.
22. Mita Y, Ishihara K, Fukuchi Y, Fukuya Y, Yasumoto K. Supplementation with chromium picolinate recovers renal Cr concentration and improves carbohydrate metabolism and renal function in type 2 diabetic mice. Biol Trace Elem Res. 2005; 105: 229-248. (Pubitemid 41009061)
23. Mita Y, Ishihara K, Ishiguru M, Takeda M, Hattori R, Murakami K, Yamada A, Yasumoto K. Elevated urinary C loss induces a reduction in renal Cr concentration and the negative Cr balance in streptozotocin-induced diabetic mice. J Nutr Sci Vitaminol. 2008; 54: 303-308.
24. Morris BW, MacNeil S, Hardisty CA, Heller S, Burgin C, Gray TA. Chromium homeostasis in patients with type II (NIDDM) diabetes. J Trace Elem Med Biol. 1999; 13: 57-61. (Pubitemid 29350165)
25. Quraishi I, Collins S, Pestaner JP, Harris T, Bagasra O. Role of zinc and zinc transporters in the molecular pathogenesis of diabetes mellitus. Med Hypotheses. 2005; 65: 887-892.
26. Reeves P. Components of the AIN-93 diets as improvements in the AIN-76A diet. J Nutr. 1997; 127: 838-841.
27. Rajpathak S, Rimm EB, Li T, Morris JS, Stampfer MJ, Willet WC, Hu FB. Lower toenail chromium in men with diabetes and cardiovascular disease compared with healthy men. Diabetes Care. 2004; 27: 2211-2216. (Pubitemid 39167187)
28. Ruíz C, Alegría A, Barberá R, Farré R, Lagarda J. Selenium, zinc and copper in plasma of patients with type 1 diabetes mellitus in different metabolic control states. J Trace Elem Med Biol. 1998; 12: 91-95. (Pubitemid 28380236)
29. Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M. Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus. Clin Chem. 2002; 48: 436-472.
30. Soinio M, Marniemi J, Laakso M, Pyörälä K, Lehto S, Rönnemaa T. Serum zinc level and coronary heart disease events in patients with type 2 diabetes. Diabetes Care. 2007; 30: 523-538.
31. Stupar J, Vrtovec M, Dolinek F. Longitudial hair chromium profiles of eldery subjects with normal glucose tolerance and type 2 diabetes mellitus. Metab Clin Exp. 2007; 56: 94-104. (Pubitemid 44855017)
32. Tang X, Shay NF. Zinc has an insulin-like effect on glucose transport mediated by phosphoinositol-3-kinase and Akt in 3T3-L1 fibroblasts and adipocytes. J Nutr. 2001; 131: 1414-1420. (Pubitemid 32422959)
33. Takita S, Wakamoto Y, Kunitsugu I, Sugiyama S, Okuda M, Houbara T. Altered tissue concentration of minerals in spontaneous diabetic rats (Goto-Kakizaki rats). The Journal of Toxicological Sciences. 2004; 29: 195-199. (Pubitemid 39264931)
34. Walter Jr RM, Uriu-Hare JY, Olin KL, Oster MH, Anawalt BD, Critchfield JW. Copper, zinc, manganese, and magnesium status and complications of diabetes mellitus. Diabetes Care. 1991; 14: 1050-1056.
35. Wenzlau JM, Juhl K, Yu L, Moua O, Sarkar SA, Gottlieb P, Rewers M, Eisenbarth GS, Jensen J, Davidson HW, Hutton JC. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci USA 2007; 104: 17040-17045. (Pubitemid 350210987)
36. Viktorínová A, Toserová E, Krizko M, Duracková Z. Altered metabolism of copper, zinc, and magnesium is associated with increased levels of glycated hemoglobin in patients with diabetes mellitus. Metabolism. 2009; 58: 1477-1482.
37. Vincent JB. Elucidating a biological role for chromium at a molecular level. Acc Chem Res. 2005; 37: 503-510.
38. Vincent JB. Chromium: celebration 50 years as an essential element? Dalton Trans. 2010; 39: 3787-3794.
39. Yildirim Z, Uçgun NI, Kiliç N, Gürsel E, Sepici-Dinçel A. Antioxidant enzymes and diabetic retinopathy. Ann N. Y. Acad Sci. 2007; 1100: 199-206.
40. Zargar AH, Bashir MI, Masoodi SR, Laway BA, Wani AI, Khan AR, Dar FA. Copper, zinc and magnesium levels in type-1 diabetes mellitus. Saudi Med J. 2002; 23: 539-542. (Pubitemid 34624922)
41. Zhao C, Wang H, Zhang J, Feng L. Correlations of trace elements, glucose and body compositions in type 2 diabetics. Wei Sheng Yan Jiu. 2008; 37: 600-601 (abstract).